ctrl K

Watchlist Price Alert

Immix Biopharma Inc. (IMMX)

NASDAQ: IMMX · Real-Time Price · USD

2.41

0.01 (0.42%)

At close: Jun 17, 2025, 10:54 AM

Immix Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	-89.52M	n/a	n/a	n/a
Cost of Revenue	n/a	5.47K	2.13K	2.47K	2.32K	1.08K
Gross Profit	n/a	-5.47K	-89.52M	-2.47K	-2.32K	-1.08K
Operating Income	-22.67M	-16.14M	-8.22M	-1.35M	-453.85K	-842.5K
Interest Income	1.02M	572.01K	0.50	179.85	101.98	109.98
Pretax Income	-21.66M	-15.57M	-8.22M	-24.38M	-1.13M	-952.26K
Net Income	-21.61M	-15.43M	-8.23M	-24.38M	-1.15M	-972.81K
Selling & General & Admin	11.38M	7.41M	4.02M	1.23M	205.7K	259.34K
Research & Development	11.29M	8.74M	4.2M	126.53K	248.15K	583.16K
Other Expenses	n/a	n/a	n/a	n/a	512.00	224.00
Operating Expenses	22.67M	16.14M	8.22M	1.35M	453.85K	842.5K
Interest Expense	n/a	n/a	497.00	179.85K	101.98K	109.98K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	16.14M	8.22M	1.35M	453.85K	842.5K
Income Tax Expense	41.04K	26.41K	10.27K	6.01K	17.55K	20.55K
Shares Outstanding (Basic)	28.29M	17.34M	13.23M	13.23M	7.77M	3.38M
Shares Outstanding (Diluted)	28.29M	17.34M	13.23M	13.23M	7.77M	3.38M
EPS (Basic)	-0.76	-0.89	-0.62	-1.84	-0.15	-0.29
EPS (Diluted)	-0.76	-0.89	-0.62	-1.84	-0.15	-0.29
EBITDA	-21.54M	-16.14M	-8.22M	-1.35M	-451.53K	-841.2K
EBIT	-21.66M	-16.14M	-8.22M	-1.35M	-453.85K	-842.28K
Depreciation & Amortization	115.39K	5.47K	2.13K	2.47K	2.32K	1.08K